Pine Michael Craig 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 10, 2023
Insider Transaction Report
Form 4
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-06+91,655→ 91,655 totalExercise: $3.26Exp: 2033-01-05→ Common Stock (91,655 underlying)
Footnotes (1)
- [F1]The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years.